At all supplement concentrations, mice receiving the combination treatment exhibited the highest levels of GSK-3β and lowest levels of p-S552-β-catenin and p-S33-37-Y41-β-catenin in tumor tissues. The gene discussed is GSK3B; the disease is neoplasm.